Survival and Perioperative Outcomes After Addition of Immunotherapy to Neoadjuvant Chemoradiotherapy for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma

Survival and Perioperative Outcomes After Addition of Immunotherapy to Neoadjuvant Chemoradiotherapy for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma

ABSTRACT Background Currently, neoadjuvant chemoradiotherapy combined with immunotherapy (NCRI) for patients with locally advanced esophageal squamous cell carcinoma (ESCC) is attracting attention. The purpose of this study was to compare the surgical outcomes and survival between patients receiving...

Full description

Saved in:
Bibliographic Details
Main Authors: Canjun Li, Xin Wang, Lei Deng, Jianyang Wang, Tao Zhang, Wenqing Wang, Wenyang Liu, Jima Lv, Qinfu Feng, Zongmei Zhou, Xiankai Chen, Ruixiang Zhang, Jianjun Qin, Yin Li, Nan Bi
Format: Article
Language:English
Published: Wiley 2025-04-01
Series:Thoracic Cancer
Subjects:
chemoradiotherapy
esophageal squamous cell carcinoma
neoadjuvant immunotherapy
pathologic complete response
survival
Online Access:https://doi.org/10.1111/1759-7714.70054
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1111/1759-7714.70054

Similar Items